A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection

Infection and Immunity

Volumn 66, Issue 12, 1998, Pages 5771-5776

  Han, Yongmoon ^a   Morrison, Richard P ^a   Cutler, Jim E ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDA VACCINE; FUNGUS VACCINE; IMMUNOGLOBULIN M; L MANN VACCINE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CANDIDA ALBICANS; COLONY FORMING UNIT; FEMALE; FUNGUS CULTURE; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VAGINA CANDIDIASIS;

EID: 0031796438     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.12.5771-5776.1998     Document Type: Article

References (44)

1. Black, C. A., F. M. Eyers, A. Russell, M. Dunkley, R. L. Clancy, and K. W. Beagley. 1998. Acute neutropenia decreases inflammation associated with murine vaginal candidiasis but has no effect on the course of infection. Infect. Immun. 66:1273-1275.
2. Brammer, K. W., and J. M. Feczko. 1988. Single-dose oral fluconazole in the treatment of vaginal candidosis. Ann. N. Y. Acad. Sci. 544:561-563.
3. Brawner, D. L., and J. E. Cutler. 1986. Variability in expression of cell surface antigens of Candida albicans during morphogenesis. Infect. Immun. 51:337-343.
4. Burritt, J. B., M. T. Quinn, M. A. Jutila, C. W. Bond, and A. J. Jesaitis. 1995. Topological mapping of neutrophil cytochrome b epitopes with phage-display libraries. J. Biol. Chem. 270:16974-16980.
5. Bushell, T. E. C., E. G. V. Evans, P. A. Llewellyn, J. D. Meaden, J. D. Milne, and D. W. Warnock. 1988. Prophylactic use of clotrimazole in recurrent vaginal candidosis. Ann. N. Y. Acad. Sci. 544:558-560.
6. Caesar-TonThat, T. C., and J. E. Cutler. 1997. A monoclonal antibody to Candida albicans enhances mouse neutrophil candidacidal activity. Infect. Immun. 65:5354-5357.
7. Casadevall, A. 1995. Antibody immunity and invasive fungal infections. Infect. Immun. 63:4211-4218.
8. Cassone, A., M. Boccanera, D. Adriani, G. Santoni, and F. De Bernardis. 1995. Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection. Infect. Immun. 63:2619-2624.
9. Denning, D. W. 1995. Can we prevent azole resistance in fungi. Lancet 346:454-455.
10. Feldmesser, M., and A. Casadevall. 1997. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection. J. Immunol. 158:790-799.
11. Fidel, P. L., M. E. Lynch, D. H. Conaway, L. Tait, and J. D. Sobel. 1995. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity. Infect. Immun. 63:547-553.
12. Fidel, P. L., M. E. Lynch, and J. D. Sobel. 1993a. Candida-specific Th-1-type responsiveness in mice with experimental vaginal candidiasis. Infect. Immun. 61:4202-4207.
13. Fidel, P. L., M. E. Lynch, and J. D. Sobel. 1993b. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect. Immun. 61:1990-1995.
14. Fleury, F. J. 1981. Adult vaginitis. Clin. Microbiol. Rev. 9:335-348.
15. Gough, P. M., D. W. Warnock, M. D. Richardson, N. J. Mansell, and J. M. King. 1984. IgA and IgG antibodies to Candida albicans in the genital tract secretions of women with or without vaginal candidosis. Sabouraudia J. Med. Vet. Mycol. 22:265-271.
16. Han, Y., and J. E. Cutler. 1995. Antibody response that protects against disseminated candidiasis. Infect. Immun. 63:2714-2719.
17. Han, Y., and J. E. Cutler. 1997. Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals. J. Infect. Dis. 175:1169-1175.
18. Han, Y., T. Kanbe, R. Cherniak, and J. E. Cutler. 1997. Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies. Infect. Immun. 65:4100-4107.
19. Hasenclever, H. F., and W. O. Mitchell. 1961. Antigenic studies of Candida. I. Observation of two antigenic groups in Candida albicans. J. Bacteriol. 82:570-573.
20. Hasenclever, H. F., W. O. Mitchell, and J. Loewe. 1961. Antigenic studies of Candida. II. Antigenic relation of Candida albicans group A and group B to Candida stellatoidea and Candida tropicalis. J. Bacteriol. 82:574-577.
21. Hazen, K. C., D. L. Brawner, M. H. Riesselman, M. A. Jutila, and J. E. Cutler. 1991. Differential adherence between hydrophobic and hydrophilic yeast cells of Candida albicans. Infect. Immun. 59:907-912.
22. Horowitz, B. J. 1991. Mycotic vulvovaginitis: a broad overview. Am. J. Obstet. Gynecol. 165:1188-1192.
23. Klein, B. S. 1997. Role of cell surface molecules of Blastomyces dermatitidis in the pathogenesis and immunobiology of blastomycosis. Semin. Respir. Med. Infect. 12:198-205.
24. Kobayashi, H., P. Giummelly, S. Takahashi, M. Ishida, J. Sato, M. Takaku, Y. Nishidate, N. Shibata, Y. Okawa, and S. Suzuki. 1991. Candida albicans serotype A strains grow in yeast extract-added Sabouraud liquid medium at pH 2.0. elaborating mannans without beta-1.2 linkage and phosphate group. Biochem. Biophys. Res. Commun. 175:1003-1009.
25. Kobayashi, H., K. Matsuda, T. Ikeda, M. Suzuki, S. Takahashi, A. Suzuki, N. Shibata, and S. Suzuki. 1994. Structures of cell wall mannans of pathogenic Candida tropicalis IFO 0199 and IFO 1647 yeast strains. Infect. Immun. 62:615-622.
26. Kobayashi, H., S.-I. Takahashi, N. Shibata, M. Miyauchi, M. Ishida, J. Sato, K. Maeda, and S. Suzuki. 1994. Structural modification of cell wall mannans of Candida albicans serotype A strains grown in yeast extract-Sabouraud liquid medium under acidic conditions. Infect. Immun. 62:968-973.
27. Morrison, R. P., K. Feilzer, and D. B. Tumas. 1995. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect. Immun. 63:4661-4668.
28. Mukherjee, J., G. Nussbaum, M. D. Scharff, and A. Casadevall. 1995. Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J. Exp. Med. 181:405-409.
29. Mukherjee, S., S. Lee, J. Mukherjee, M. D. Scharff, and A. Casadevall. 1994. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. Infect. Immun. 62:1079-1088.
30. Odds, F. C. 1988. Candida and candidosis. Bailiiere Tindall, London, England.
31. Ott, A. K., K. Franklyn, J. R. Warmington, and R. B. Ashman. 1990. A Candida-specific antibody in patients with vaginitis. Med. J. Aust. 152:390-391.
32. Pincus, S. H., R. L. Cole, E. Kamanga-Sollo, and S. H. Fischer. 1993. Interaction of group B streptococcal opacity variants with the host defense system. Infect. Immun. 61:3761-3768.
33. Qian, Q., M. A. Jutila, N. van Rooijen, and J. E. Cutler. 1994. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J. Immunol. 152:5000-5008.
34. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
35. Romani, L. 1997. The T cell response against fungal infections. Curr. Opin. Immunol. 9:484-490.
36. Sanglard, D., K. Kuchler, F. Ischer, J.-L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
37. Segal, E., N. Vardinon, J. Foldes, J. Schwartz, and E. Eylan. 1977. Serum anti-candida albicans antibodies in candidal and non-candidal vaginitis. Zentralbl. Bakteriol. Hyg. 239:548-553.
38. Shibata, N., K. Ikuta, T. Imai, Y. Satoh, R. Satoh, A. Suzuki, C. Kojima, H. Kobayashi, K. Hisamichi, and S. Suzuki. 1995. Existence of branched side chains in the cell wall mannan of pathogenic yeast, Candida albicans. J. Biol. Chem. 270:1113-1122.
39. Sobel, J. D. 1985. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am. J. Obstet. Gynecol. 152:924-935.
40. Sobel, J. D. 1988. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann. N. Y. Acad. Sci. 544:547-557.
41. Sobel, J. D. 1992. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin. Infect. Dis. 14(Suppl. 1):S148-S153.
42. White, T. C. 1997. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41:1482-1487.
43. Yuan, R., A. Casadevall, G. Spira, and M. D. Scharff. 1995. Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J. Immunol. 154:1810-1816.
44. Yuan, Y., K. Lyng, Y.-X. Zhang, D. D. Rockey, and R. P. Morrison. 1992. Monoclonal antibodies define genus-specific, species-specific, and cross-reactive epitopes of the chlamydial 60-kilodalton heat shock protein (hsp60): specific immunodetection and purification of chlamydial hsp60. Infect. Immun. 60:2288-2296.